Advertisement

Metabolic Brain Disease

, Volume 33, Issue 6, pp 1955–1959 | Cite as

Correlation of serum levels and gene expression of tumor necrosis factor-α-induced protein-8 like-2 with Parkinson disease severity

  • Ebrahim Kouchaki
  • Reza Daneshvar Kakhaki
  • Omid Reza Tamtaji
  • Ehsan Dadgostar
  • Mohammad Behnam
  • Alireza Zaribaf
  • Hassan Nikoueinejad
  • Hossein Akbari
  • Zatollah Asemi
Original Article

Abstract

Different immune-mediated mechanisms involved in the pathogenesis of Parkinson disease (PD) as a neurodegenerative and inflammatory disease. According to our knowledge, there is no report evaluating Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2), a cytokine maintaining immune homeostasis, in PD. We analyzed the correlation of the serum levels and circulatory gene expression of TIPE2 with severity of PD. In this case-control study, 43 patients with PD and 40 healthy subjects were enrolled. The diagnosis of PD was performed byclinical diagnostic criteria of the UK Parkinson’s Disease Society Brain Bank. The severity of PD was evaluated by modified Hoehn and Yahr (H and Y) scale. Serum levels and gene expression of TIPE2 were assessed by Elisa and real time PCR, respectively. The mean serum levels and gene expression of TIPE2 in patients with PD did not have significant difference compared to healthy subjects. Linear multiple regression analysis showed that increased serum levels of TIPE2 are positively related to age and severity of PD (P ≤ 0.0001). In addition, the gene expression of TIPE2 was found to be associated with age (P < 0.0001). Our study showed that the serum levels of TIPE2 and its gene expression might be important prognostic biomarkers of PD.

Keywords

Parkinson disease TIPE2 TNFAIP8 Gene expression 

Notes

Acknowledgements

This work was supported by grants from the Deputy of Research, Kashan University of Medical Sciences, Kashan, Iran (No. 95124).

Author’s contributions

ED and HN contributed in the conception or design of the work, analysis and drafting of the manuscript. EK, RD-K, O-RT, MB, AZ and HA contributed in conception and manuscript drafting. ZA contributed in revised version. The final version was confirmed by all authors for submission.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, Zhu F, wang Q, Wang J, Wang X, Chen YH, Zhang L (2013) Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 12:149CrossRefGoogle Scholar
  2. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115(12):1599–1608CrossRefGoogle Scholar
  3. Dufek M, Hamanová M, Lokaj J, Goldemund D, Rektorová I, Michálková Z, Sheardova K, Rektor I (2009) Serum inflammatory biomarkers in Parkinson's disease. Parkinsonism Relat Disord 15(4):318–320CrossRefGoogle Scholar
  4. Finkelstein MM, Jerrett M (2007) A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environ Res 104(3):420–432CrossRefGoogle Scholar
  5. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006 Feb 28) In vivo imaging of microglial activation with [11 C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21(2):404–412CrossRefGoogle Scholar
  6. Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O (2015) Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology 85(21):1834–1842CrossRefGoogle Scholar
  7. Junn E, Mouradian MM (2001) Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78(2):374–383CrossRefGoogle Scholar
  8. Kong L, Liu K, Zhang Y-Z, Jin M, Wu B-R, Wang W-Z, Li W, Nan YM, Chen YH (2013) Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C. Hepatol Int 7(3):844–849CrossRefGoogle Scholar
  9. Kouchaki E, Kakhaki RD, Tamtaji OR, Dadgostar E, Behnam M, Nikoueinejad H, Akbari H (2018) Increased serum levels of TNF-α and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg 166:76–79CrossRefGoogle Scholar
  10. Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L (2009) Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 133(3):422–427CrossRefGoogle Scholar
  11. Lou Y, Liu S, Zhang C, Zhang G, Li J, Ni M, An G, Dong M, Liu X, Zhu F, Zhang W, Gao F, Chen YH, Zhang Y (2013) Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein. J Immunol 191:4849–4857CrossRefGoogle Scholar
  12. Ma Y, Liu X, Wei Z, Wang X, Wang Z, Zhong W, Li Y, Zhu F, Guo C, Zhang L, Wang X (2013) The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children. Scand J Immunol 78(6):523–528CrossRefGoogle Scholar
  13. Peng J, Andersen J (2003) The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. IUBMB Life 55(4–5):267–271CrossRefGoogle Scholar
  14. Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, Onofrj M (2009) Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun 23(1):55–63CrossRefGoogle Scholar
  15. Ruiz-Martínez J, Azcona LJ, Bergareche A, Martí-Massó JF, Paisán-Ruiz C (2017) Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease. Neurol Genet 3(5):e177CrossRefGoogle Scholar
  16. Scalzo P, Kümmer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease. J Neuroimmunol 216(1):122–125CrossRefGoogle Scholar
  17. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH (2008) TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133(3):415–426CrossRefGoogle Scholar
  18. Sun H, Zhuang G, Chai L, Wang Z, Johnson D, Ma Y, Chen YH (2012) TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase–Rac pathway. J Immunol 189(6):2768–2773CrossRefGoogle Scholar
  19. Suo LG, Cui YY, Bai Y, Qin XJ (2016) Anti-inflammatory TIPE2 inhibits angiogenic VEGF in retinal pigment epithelium. Mol Immunol 73:46–52CrossRefGoogle Scholar
  20. Taghizadeh M, Tamtaji OR, Dadgostar E, Kakhaki RD, Bahmani F, Abolhassani J et al (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Neurochem Int 108:183–189CrossRefGoogle Scholar
  21. Wang Z, Fayngerts S, Wang P, Sun H, Johnson DS, Ruan Q, Guo W, Chen YH (2012) TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci 109(38):15413–15418CrossRefGoogle Scholar
  22. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S (2011) Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 48(9):1203–1208CrossRefGoogle Scholar
  23. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, Chen YH, Shi Y (2009) Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 16:89–90CrossRefGoogle Scholar
  24. Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y, Qu Z, Guo C, Chen Y, Zhang Y, Liu S (2010) Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 47:2435–2442CrossRefGoogle Scholar
  25. Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C, Chen YH, Zhang L (2011) The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 48(9):1209–1215CrossRefGoogle Scholar
  26. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F (2012) TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 287(39):32546–32555CrossRefGoogle Scholar
  27. Zhang G, Zhang W, Lou Y, Xi W, Cui J, Geng M, Zhu F, Chen YH, Liu S (2013) TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation. Cell Cycle 12(3):501–510CrossRefGoogle Scholar
  28. Zhang YH, Yan HQ, Wang F, Wang YY, Jiang YN, Wang YN et al (2015) TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation. Int J Oncol 46(1):254–264CrossRefGoogle Scholar
  29. Zhou T, Zu G, Zhou L, Che N, Guo J, Liang Z (2016) Ginsenoside Rg1 prevents cerebral and cerebellar injury induced by obstructive jaundice in rats via inducing expression of TIPE-2. Neurosci Lett 610:193–199CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurologyKashan University of Medical SciencesKashanIran
  2. 2.Halal Research Center of IRI, FDATehranIran
  3. 3.Physiology Research CenterKashan University of Medical SciencesKashan, I.R.Iran
  4. 4.Student Research CommitteeKashan University of Medical SciencesKashanIran
  5. 5.Department of ImmunologyBaqiyatallah University of Medical SciencesTehranIran
  6. 6.Nephrology and Urology Research CenterBaqiyatallah University of Medical Sciences, Baqiyatallah HospitalTehran, I.RIran
  7. 7.Department of Biostatistics and Public Health, Faculty of HealthKashan University of Medical SciencesKashanIran
  8. 8.Research Center for Biochemistry and Nutrition in Metabolic DiseasesKashan University of Medical SciencesKashan, I.R.Iran

Personalised recommendations